Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44416   clinical trials with a EudraCT protocol, of which   7423   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     

    < Back to search results

    Download PDF

    Clinical Trial Results:
    Tweede Immunisatie Men C (TIM)-studie

    Summary
    EudraCT number
    2011-000375-13
    Trial protocol
    NL  
    Global end of trial date
    19 Nov 2014

    Results information
    Results version number
    v1(current)
    This version publication date
    07 Oct 2026
    First version publication date
    07 Oct 2026
    Other versions

    Trial information

    Close Top of page
    Trial identification
    Sponsor protocol code
    LIS-144
    Additional study identifiers
    ISRCTN number
    -
    US NCT number
    -
    WHO universal trial number (UTN)
    -
    Other trial identifiers
    METC-nummer: R-11.09E/TIM , ABR-nummer: NL35207.100.11 , Clinical Trial Register Nummer: NTR 3521
    Sponsors
    Sponsor organisation name
    RIVM
    Sponsor organisation address
    PO Box 1, Bilthoven, Netherlands, 3720 BA
    Public contact
    Clinical Expertise Centre, RIVM, mensgebonden-onderzoek@rivm.nl
    Scientific contact
    Clinical Expertise Centre, RIVM, mensgebonden-onderzoek@rivm.nl
    Paediatric regulatory details
    Is trial part of an agreed paediatric investigation plan (PIP)
    No
    Does article 45 of REGULATION (EC) No 1901/2006 apply to this trial?
    No
    Does article 46 of REGULATION (EC) No 1901/2006 apply to this trial?
    No
    Results analysis stage
    Analysis stage
    Final
    Date of interim/final analysis
    27 May 2015
    Is this the analysis of the primary completion data?
    Yes
    Primary completion date
    19 Nov 2014
    Global end of trial reached?
    Yes
    Global end of trial date
    19 Nov 2014
    Was the trial ended prematurely?
    No
    General information about the trial
    Main objective of the trial
    To determine the appropriate age for a second immunization with the Meningococcal C conjugated vaccine.
    Protection of trial subjects
    During this study the subjects will receive one dose of NeisVac-C™(Registration number: RVG 26343). NeisVac-C™ is a registered vaccine and currently used in the Dutch NIP for all children aged 14 months. Furthermore, the vaccine has already been used in the Netherlands (and other countries) in the same age group (children 10, 12 and 15 years of age) during the catch-up campaign in 2002. During the catch-up campaign over 3 million children were vaccinated and only 1512 developed an adverse reaction. It is therefore unlikely that serious side effects will occur that can lead to premature termination of the study. The invasive study procedures (vaccination and venapunctures) will be carried out by experienced and qualified persons according to standard operating procedures. A local anesthetic (Xylocaine spray) can be used to minimize the pain of the venapuncture. Furthermore, the burden and risk of blood and saliva sampling is considered low. Blood collection could result in a small bruise at the location of injection, which will disappear within a few days.
    Background therapy
    -
    Evidence for comparator
    -
    Actual start date of recruitment
    02 May 2011
    Long term follow-up planned
    Yes
    Long term follow-up rationale
    Scientific research
    Long term follow-up duration
    3 Years
    Independent data monitoring committee (IDMC) involvement?
    No
    Population of trial subjects
    Number of subjects enrolled per country
    Country: Number of subjects enrolled
    Netherlands: 268
    Worldwide total number of subjects
    268
    EEA total number of subjects
    268
    Number of subjects enrolled per age group
    In utero
    0
    Preterm newborn - gestational age < 37 wk
    0
    Newborns (0-27 days)
    0
    Infants and toddlers (28 days-23 months)
    0
    Children (2-11 years)
    91
    Adolescents (12-17 years)
    177
    Adults (18-64 years)
    0
    From 65 to 84 years
    0
    85 years and over
    0

    Subject disposition

    Close Top of page
    Recruitment
    Recruitment details
    Persons of 10-15 years of age (year 1996-2002) who have previously received one MenCC vaccination and are living in or around Utrecht (Leidsche Rijn) (n=4500, 1500 per age group) were invited for participation in the study. Recruitment was done via an invitation letter to the parents. First inclusion: 3-Oct-2011.

    Pre-assignment
    Screening details
    Inclusion and exclusion was checked by the PI: inclusion -10-, 12, 15-years received primary vaccination MenCC; good general health; Received all regular vaccines of Dutch NIP exclusion: -acute illness; antibiotic use; serious disease, allergy to vaccin; immune deficiency; neurologic disorder; pregnancy; previous Meningococcal disease

    Period 1
    Period 1 title
    MenC immunization (overall period)
    Is this the baseline period?
    Yes
    Allocation method
    Not applicable
    Blinding used
    Not blinded

    Arms
    Are arms mutually exclusive
    Yes

    Arm title
    10 year olds
    Arm description
    immune response to a second MenCC vaccination in age group 10 years old
    Arm type
    Experimental

    Investigational medicinal product name
    NeisVac-C™
    Investigational medicinal product code
    RVG 26343
    Other name
    Pharmaceutical forms
    Suspension for injection in pre-filled syringe
    Routes of administration
    Intramuscular use, Injection
    Dosage and administration details
    One dose of 0.5 ml for intramuscular injection contains 10 microgram of Neisseria meningitidis group C (strain C11) polysaccharide (de-O-acetylated). The polysaccharide is conjugated to 10-20 micrograms of tetanus toxoid and is adsorbed to aluminium hydroxide (0.5 mg). Other additive products are sodium chloride and water for injections. The NeisVac-C™ vaccine (0.5 ml) is injected intramuscularly in the upper arm. This is a customary and well-accepted route of administration of this vaccine.

    Arm title
    12 year olds
    Arm description
    immune response to a second MenCC vaccination in age group 12 years old
    Arm type
    Experimental

    Investigational medicinal product name
    NeisVac-C™
    Investigational medicinal product code
    RVG 26343
    Other name
    Pharmaceutical forms
    Suspension for injection in pre-filled syringe
    Routes of administration
    Intramuscular use, Injection
    Dosage and administration details
    One dose of 0.5 ml for intramuscular injection contains 10 microgram of Neisseria meningitidis group C (strain C11) polysaccharide (de-O-acetylated). The polysaccharide is conjugated to 10-20 micrograms of tetanus toxoid and is adsorbed to aluminium hydroxide (0.5 mg). Other additive products are sodium chloride and water for injections. The NeisVac-C™ vaccine (0.5 ml) is injected intramuscularly in the upper arm. This is a customary and well-accepted route of administration of this vaccine.

    Arm title
    15 year olds
    Arm description
    immune response to a second MenCC vaccination in age group 15 years old
    Arm type
    Experimental

    Investigational medicinal product name
    NeisVac-C™
    Investigational medicinal product code
    RVG 26343
    Other name
    Pharmaceutical forms
    Suspension for injection in pre-filled syringe
    Routes of administration
    Intramuscular use, Injection
    Dosage and administration details
    One dose of 0.5 ml for intramuscular injection contains 10 microgram of Neisseria meningitidis group C (strain C11) polysaccharide (de-O-acetylated). The polysaccharide is conjugated to 10-20 micrograms of tetanus toxoid and is adsorbed to aluminium hydroxide (0.5 mg). Other additive products are sodium chloride and water for injections. The NeisVac-C™ vaccine (0.5 ml) is injected intramuscularly in the upper arm. This is a customary and well-accepted route of administration of this vaccine.

    Number of subjects in period 1
    10 year olds 12 year olds 15 year olds
    Started
    91
    91
    86
    T1 (1 month after T0)
    88
    90
    85
    T2 (1 year after T0)
    85
    89
    83
    T3 (3 years after T0) (follow-up)
    66
    76
    59
    Completed
    66
    76
    59
    Not completed
    25
    15
    27
         Didn't want to participate with the follow-up
    19
    13
    24
         No blood
    3
    -
    -
         Lost to follow-up
    3
    2
    3

    Baseline characteristics

    Close Top of page
    Baseline characteristics reporting groups
    Reporting group title
    10 year olds
    Reporting group description
    immune response to a second MenCC vaccination in age group 10 years old

    Reporting group title
    12 year olds
    Reporting group description
    immune response to a second MenCC vaccination in age group 12 years old

    Reporting group title
    15 year olds
    Reporting group description
    immune response to a second MenCC vaccination in age group 15 years old

    Reporting group values
    10 year olds 12 year olds 15 year olds Total
    Number of subjects
    91 91 86 268
    Age categorical
    Units: Subjects
        In utero
    0 0 0 0
        Preterm newborn infants (gestational age < 37 wks)
    0 0 0 0
        Newborns (0-27 days)
    0 0 0 0
        Infants and toddlers (28 days-23 months)
    0 0 0 0
        Children (2-11 years)
    91 0 0 91
        Adolescents (12-17 years)
    0 91 86 177
        Adults (18-64 years)
    0 0 0 0
        From 65-84 years
    0 0 0 0
        85 years and over
    0 0 0 0
    Age continuous
    Units: years
        arithmetic mean (standard deviation)
    9.9 ( 0.3 ) 12.0 ( 0.3 ) 15.0 ( 0.3 ) -
    Gender categorical
    Units: Subjects
        Female
    53 44 41 138
        Male
    38 47 45 130

    End points

    Close Top of page
    End points reporting groups
    Reporting group title
    10 year olds
    Reporting group description
    immune response to a second MenCC vaccination in age group 10 years old

    Reporting group title
    12 year olds
    Reporting group description
    immune response to a second MenCC vaccination in age group 12 years old

    Reporting group title
    15 year olds
    Reporting group description
    immune response to a second MenCC vaccination in age group 15 years old

    Subject analysis set title
    Age group 10 at T0
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 10 T0

    Subject analysis set title
    Age group 10 at T1
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 10 T1

    Subject analysis set title
    Age group 10 at T2
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 10 at T2

    Subject analysis set title
    Age group 12 at T0
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 12 at T0

    Subject analysis set title
    Age group 12 at T1
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 12 at T1

    Subject analysis set title
    Age group 12 at T2
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 12 at T2

    Subject analysis set title
    Age group 15 at T0
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 15 at T0

    Subject analysis set title
    Age group 15 at T1
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 15 at T1

    Subject analysis set title
    Age group 15 at T2
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 15 at T2

    Subject analysis set title
    Age group 10 at T3
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 10 years old, sample T3

    Subject analysis set title
    Age group 12 at T3
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 12 years old , sample T3

    Subject analysis set title
    Age group 15 at T3
    Subject analysis set type
    Sub-group analysis
    Subject analysis set description
    Age group 15 years old, sample T3

    Primary: Geometric Mean Titers (GMTs) of MenC SBA levels at T0

    Close Top of page
    End point title
    Geometric Mean Titers (GMTs) of MenC SBA levels at T0
    End point description
    Geometric Mean Titers (GMTs) of Meningococcal Serogroup C (MenC) Specific Serum Bactericidal Antibody (SBA) prior to (T0) the MenC Conjugate Booster.
    End point type
    Primary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    91
    91
    86
    Units: GMT
        geometric mean (confidence interval 95%)
    4.0 (2.9 to 5.4)
    8.2 (5.3 to 12.6)
    13.1 (8.1 to 21.0)
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 12 at T0
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    182
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.006 [1]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [1] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 15 at T0
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    15 year olds v 10 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [2]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [2] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 12 vs. 15 at T0
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.459 [3]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [3] - P-values were adjusted for three comparisons with Bonferroni correction.

    Primary: Geometric Mean Titers (GMTs) of MenC SBA levels at T1

    Close Top of page
    End point title
    Geometric Mean Titers (GMTs) of MenC SBA levels at T1
    End point description
    Geometric Mean Titers (GMTs) of Meningococcal Serogroup C (MenC) Specific Serum Bactericidal Antibody (SBA) 1 Month (T1) after the MenC Conjugate Booster.
    End point type
    Primary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    89 [4]
    85
    Units: GMT
        geometric mean (confidence interval 95%)
    31.564 (26.899 to 37.038)
    45.175 (38.608 to 52.859)
    47.289 (40.422 to 55.322)
    Notes
    [4] - 1 insufficient blood sample
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 12 at T1
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.021 [5]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [5] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 15 at T1
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.003 [6]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [6] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 12 vs. 15 at T1
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [7]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [7] - P-values were adjusted for three comparisons with Bonferroni correction.

    Primary: Geometric Mean Titers (GMTs) of MenC SBA levels at T2

    Close Top of page
    End point title
    Geometric Mean Titers (GMTs) of MenC SBA levels at T2
    End point description
    Geometric Mean Titers (GMTs) of Meningococcal Serogroup C (MenC) Specific Serum Bactericidal Antibody (SBA) 1 Year (T2) after the MenC Conjugate Booster.
    End point type
    Primary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: GMT
        geometric mean (confidence interval 95%)
    1.987 (1.602 to 2.247)
    4.165 (3.444 to 5.038)
    6.292 (5.272 to 7.509)
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 12 at T2
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [8]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [8] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 15 at T2
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [9]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [9] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 12 vs. 15 at T2
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T0 were determined using the Mann-Whitney U test. Differences between groups in SBA GMTs at T1 and T2 were determined with linear regression analyses, adjusting for titers at T0.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.021 [10]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [10] - P-values were adjusted for three comparisons with Bonferroni correction.

    Primary: Proportion of Participants with an SBA titer >=8 at T0

    Close Top of page
    End point title
    Proportion of Participants with an SBA titer >=8 at T0
    End point description
    Percentage of Participants with an SBA titer >=8 prior to (T0) the MenC Conjugate Booster. Proportion and 95% confidence intervals (95%CIs) of participants with an SBA titer >=8 were calculated using the Agresti-Coull method.
    End point type
    Primary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    91
    91
    86
    Units: proportion >=8
        arithmetic mean (confidence interval 95%)
    19 (12 to 28)
    34 (25 to 45)
    45 (35 to 56)
    Statistical analysis title
    SBA titer >=8 analysis 10 vs. 12 at T0
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    182
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.057 [11]
    Method
    Chi-squared
    Confidence interval
    Notes
    [11] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    SBA titer >=8 analysis 10 vs. 15 at T0
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [12]
    Method
    Chi-squared
    Confidence interval
    Notes
    [12] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    SBA titer >=8 analysis 12 vs. 15 at T0
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.375 [13]
    Method
    Chi-squared
    Confidence interval
    Notes
    [13] - P-values were adjusted for three comparisons with Bonferroni correction

    Primary: Proportion of Participants with an SBA titer >=8 at T1

    Close Top of page
    End point title
    Proportion of Participants with an SBA titer >=8 at T1
    End point description
    Percentage of Participants with an SBA titer >=8 1 month (T1) after the MenC Conjugate Booster. Proportion and 95% confidence intervals (95%CIs) of participants with an SBA titer >=8 were calculated using the Agresti-Coull method.
    End point type
    Primary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: proportion >=8
        arithmetic mean (confidence interval 95%)
    100 (95 to 100)
    100 (95 to 100)
    100 (95 to 100)
    Statistical analysis title
    SBA titer >=8 analysis 10 vs. 12 at T1
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [14]
    Method
    Chi-squared
    Confidence interval
    Notes
    [14] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    SBA titer >=8 analysis 10 vs. 15 at T1
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [15]
    Method
    Chi-squared
    Confidence interval
    Notes
    [15] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    SBA titer >=8 analysis 12 vs. 15 at T1
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [16]
    Method
    Chi-squared
    Confidence interval
    Notes
    [16] - P-values were adjusted for three comparisons with Bonferroni correction

    Primary: Proportion of Participants with an SBA titer >=8 at T2

    Close Top of page
    End point title
    Proportion of Participants with an SBA titer >=8 at T2
    End point description
    Percentage of Participants with an SBA titer >=8 1 year (T2) after the MenC Conjugate Booster. Proportion and 95% confidence intervals (95%CIs) of participants with an SBA titer >=8 were calculated using the Agresti-Coull method.
    End point type
    Primary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: proportion >=8
        arithmetic mean (confidence interval 95%)
    100 (95 to 100)
    100 (95 to 100)
    100 (95 to 100)
    Statistical analysis title
    SBA titer >=8 analysis 10 vs. 12 at T2
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [17]
    Method
    Chi-squared
    Confidence interval
    Notes
    [17] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    SBA titer >=8 analysis 10 vs. 15 at T2
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [18]
    Method
    Chi-squared
    Confidence interval
    Notes
    [18] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    SBA titer >=8 analysis 12 vs. 15 at T2
    Statistical analysis description
    An SBA titer >=8 was considered as international correlate of protection. Differences between groups in proportion of participants with an SBA titer >=8 was determined with Chi square test
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [19]
    Method
    Chi-squared
    Confidence interval
    Notes
    [19] - P-values were adjusted for three comparisons with Bonferroni correction

    Primary: Geometric Mean Titers (GMTs) of MenC SBA levels at T3

    Close Top of page
    End point title
    Geometric Mean Titers (GMTs) of MenC SBA levels at T3
    End point description
    Geometric Mean Titers (GMTs) of Meningococcal Serogroup C (MenC) Specific Serum Bactericidal Antibody (SBA) 3 years (T3) after the MenC Conjugate Booster vaccination.
    End point type
    Primary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: GMT
        geometric mean (confidence interval 95%)
    619 (489 to 782)
    1992 (1568 to 2531)
    3678 (2966 to 4562)
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 12 at T3
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T3 were determined with linear regression analyses, adjusting for titers at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [20]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [20] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 10 vs. 15 at T3
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T3 were determined with linear regression analyses, adjusting for titers at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [21]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [21] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT MenC SBA levels analysis 12 vs. 15 at T3
    Statistical analysis description
    Differences between groups in Serum Bactericidal Antibody (SBA) Geometric Mean Titers (GMTs) at T3 were determined with linear regression analyses, adjusting for titers at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.006 [22]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [22] - P-values were adjusted for three comparisons with Bonferroni correction.

    Primary: Proportion of Participants with an SBA titer >=8 at T3

    Close Top of page
    End point title
    Proportion of Participants with an SBA titer >=8 at T3
    End point description
    Percentage of Participants with an SBA titer >8 3 years (T3) after the MenC Conjugate Booster. Proportions with 95% CI of participants with an rSBA >=8 were calculated using the Wilson score interval with continuity correction.
    End point type
    Primary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: proportion >8
        number (confidence interval 95%)
    100 (95 to 100)
    100 (95 to 100)
    100 (95 to 100)
    Statistical analysis title
    Proportion GMT SBA >=8 10 vs. 12 at T3
    Statistical analysis description
    Differences in proportion of participants GMT SBA >-=8 at T3 were tested with the Chi-square test.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1
    Method
    Chi-squared
    Confidence interval
    Statistical analysis title
    Proportion GMT SBA >=8 10 vs. 15 at T3
    Statistical analysis description
    Differences in proportion of participants GMT SBA >-=8 at T3 were tested with the Chi-square test.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1
    Method
    Chi-squared
    Confidence interval
    Statistical analysis title
    Proportion GMT SBA >=8 12 vs. 15 at T3
    Statistical analysis description
    Differences in proportion of participants GMT SBA >-=8 at T3 were tested with the Chi-square test.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1
    Method
    Chi-squared
    Confidence interval

    Secondary: GMC MenC-PS specific IgG antibodies at T0

    Close Top of page
    End point title
    GMC MenC-PS specific IgG antibodies at T0
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G (IgG) prior to (T0) the MenC Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    91
    91
    86
    Units: ug/mL
        geometric mean (confidence interval 95%)
    0.26 (0.22 to 0.31)
    0.32 (0.26 to 0.39)
    0.40 (0.31 to 0.51)
    Statistical analysis title
    GMC Men C IgG antibodies analysis 10 vs. 12 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    182
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.444 [23]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [23] - linear regression analyses, adjusting for concentrations at T0. Differences in GMC ratios between groups were determined with independent sample t-tests. P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    GMC Men C IgG antibodies analysis 10 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.018 [24]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [24] - linear regression analyses, adjusting for concentrations at T0. Differences in GMC ratios between groups were determined with independent sample t-tests. P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    GMC Men C IgG antibodies analysis 12 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.579 [25]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [25] - linear regression analyses, adjusting for concentrations at T0. Differences in GMC ratios between groups were determined with independent sample t-tests. P-values were adjusted for three comparisons with Bonferroni correction

    Secondary: GMC MenC-PS specific IgG antibodies at T1

    Close Top of page
    End point title
    GMC MenC-PS specific IgG antibodies at T1
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G (IgG) 1 Month (T1) after the MenC Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: ug/mL
        geometric mean (confidence interval 95%)
    134 (117.0 to 153.4)
    193.6 (168.2 to 222.3)
    174.3 (147.5 to 206.0)
    Statistical analysis title
    GMC Men C IgG antibodies analysis 10 vs. 12 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [26]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [26] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    GMC Men C IgG antibodies analysis 10 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.063 [27]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [27] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    GMC Men C IgG antibodies analysis 12 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [28]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [28] - P-values were adjusted for three comparisons with Bonferroni correction

    Secondary: GMC MenC-PS specific IgG antibodies at T2

    Close Top of page
    End point title
    GMC MenC-PS specific IgG antibodies at T2
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G (IgG) 1 Year (T2) after the MenC Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: ug/mL
        geometric mean (confidence interval 95%)
    12.2 (10.2 to 14.4)
    23.3 (19.3 to 28.0)
    33.7 (28.4 to 39.9)
    Statistical analysis title
    GMC Men C IgG antibodies analysis 10 vs. 12 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [29]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [29] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    GMC Men C IgG antibodies analysis 10 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [30]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [30] - P-values were adjusted for three comparisons with Bonferroni correction
    Statistical analysis title
    GMC Men C IgG antibodies analysis 12 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. GMC ratios indicate the level of increase (T1/T0) or decrease (T1/T2) between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.033 [31]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [31] - P-values were adjusted for three comparisons with Bonferroni correction

    Secondary: Men-C PS specific IgG memory B-cell responses at T0

    Close Top of page
    End point title
    Men-C PS specific IgG memory B-cell responses at T0
    End point description
    Frequency of circulating MenC-PS-specific IgG memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    17
    13
    14
    Units: MenC-specific memory B cells
        geometric mean (confidence interval 95%)
    0.10 (0.03 to 0.39)
    0.08 (0.01 to 0.41)
    0.26 (0.06 to 1.18)
    Statistical analysis title
    Men-C PS IgG memory B cells T0 10 vs. 12 years old
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    30
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.7418
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgG memory B cells T0 10 vs. 15 years old
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    31
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.465
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgG memory B cells T0 12 vs. 15 years old
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    27
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.3933
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Men-C PS specific IgG memory B-cell responses at T1

    Close Top of page
    End point title
    Men-C PS specific IgG memory B-cell responses at T1
    End point description
    Frequency of circulating MenC-PS-specific IgG memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    19
    14
    18
    Units: MenC-specific memory B cells
        geometric mean (confidence interval 95%)
    45.27 (31.03 to 66.06)
    140.87 (116.76 to 169.96)
    68.26 (45.47 to 102.45)
    Statistical analysis title
    Men-C IgG memory B cells T1 10 vs. 12 years old
    Statistical analysis description
    Frequency of circulating MenC-PS-specific memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    33
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.0001
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C IgG memory B cells T1 10 vs. 15 years old
    Statistical analysis description
    Frequency of circulating MenC-PS-specific memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    37
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1131
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C IgG memory B cells T1 12 vs. 15 years old
    Statistical analysis description
    Frequency of circulating MenC-PS-specific memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    32
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0031
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Men-C PS specific IgG memory B-cell responses at T2

    Close Top of page
    End point title
    Men-C PS specific IgG memory B-cell responses at T2
    End point description
    Frequency of circulating MenC-PS-specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    17
    14
    18
    Units: MenC-specific memory B cells
        geometric mean (confidence interval 95%)
    5.08 (1.39 to 18.63)
    24.45 (15.93 to 37.51)
    11.76 (4.27 to 32.42)
    Statistical analysis title
    Men-C PS IgG memory B cells T2 10 vs. 12 years old
    Statistical analysis description
    Frequency of circulating MenC-PS-specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    31
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0214
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgG memory B cells T2 10 vs. 15 years old
    Statistical analysis description
    Frequency of circulating MenC-PS-specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    35
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1625
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgG memory B cells T2 12 vs. 15 year old
    Statistical analysis description
    Frequency of circulating MenC-PS-specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    32
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.4139
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: GMC MenC-PS specific IgA in serum at T0

    Close Top of page
    End point title
    GMC MenC-PS specific IgA in serum at T0
    End point description
    Geometric mean concentrations (GMCs) of MenC-polysaccharide specific IgA in serum prior to (T0) the MenC conjugate booster vaccination.
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    81 [32]
    86 [33]
    75 [34]
    Units: ng/mL
        geometric mean (confidence interval 95%)
    13.3 (10.0 to 17.6)
    24.7 (17.4 to 35.0)
    36.1 (25.5 to 51.0)
    Notes
    [32] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [33] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [34] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 10 vs. 12 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T0 between age groups were made using the Mann–Whitney U test. Comparisons between age groups at T1 and T2 were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    167
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.051 [35]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [35] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 10 vs. 15 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T0 between age groups were made using the Mann–Whitney U test. Comparisons between age groups at T1 and T2 were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    156
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [36]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [36] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 12 vs. 15 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T0 between age groups were made using the Mann–Whitney U test. Comparisons between age groups at T1 and T2 were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    161
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.21 [37]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [37] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgA in serum at T1

    Close Top of page
    End point title
    GMC MenC-PS specific IgA in serum at T1
    End point description
    Geometric mean concentrations (GMCs) of MenC-polysaccharide specific IgA in serum 1 month (T1) after the MenC conjugate booster vaccination.
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    83 [38]
    86 [39]
    75 [40]
    Units: ng/mL
        geometric mean (confidence interval 95%)
    7464 (5827 to 9560)
    18641 (15308 to 22700)
    21290 (16598 to 27309)
    Notes
    [38] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [39] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [40] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 10 vs. 12 at T1
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T1 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    169
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [41]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [41] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 10 vs. 15 at T1
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T1 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    158
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [42]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [42] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 12 vs. 15 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T1 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    161
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [43]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [43] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgA in serum at T2

    Close Top of page
    End point title
    GMC MenC-PS specific IgA in serum at T2
    End point description
    Geometric mean concentrations (GMCs) of MenC-polysaccharide specific IgA in serum 1 Year (T2) after the MenC conjugate booster vaccination.
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    83 [44]
    86 [45]
    75 [46]
    Units: ng/mL
        geometric mean (confidence interval 95%)
    730 (568 to 938)
    2243 (1773 to 2838)
    3557 (2749 to 4601)
    Notes
    [44] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [45] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [46] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 10 vs. 12 at T2
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T2 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    169
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [47]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [47] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 10 vs. 15 at T2
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T2 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    158
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [48]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [48] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in serum 12 vs. 15 at T2
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in serum at T2 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    161
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.174 [49]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [49] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgA in saliva at T0

    Close Top of page
    End point title
    GMC MenC-PS specific IgA in saliva at T0
    End point description
    Geometric mean concentrations (GMCs) of MenC-polysaccharide specific IgA in saliva prior to (T0) the MenC conjugate booster vaccination.
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    81 [50]
    86 [51]
    75 [52]
    Units: ng/mL
        geometric mean (confidence interval 95%)
    4.8 (4.1 to 5.6)
    6.5 (5.3 to 7.9)
    9.0 (7.4 to 11.0)
    Notes
    [50] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [51] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [52] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 10 vs. 12 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T0 between age groups were made using the Mann–Whitney U test. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    167
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.159 [53]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [53] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 10 vs. 15 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T0 between age groups were made using the Mann–Whitney U test. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    156
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [54]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [54] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 12 vs. 15 at T0
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T0 between age groups were made using the Mann–Whitney U test. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    161
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.03 [55]
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Notes
    [55] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgA in saliva at T1

    Close Top of page
    End point title
    GMC MenC-PS specific IgA in saliva at T1
    End point description
    Geometric mean concentrations (GMCs) of MenC-polysaccharide specific IgA in saliva 1 Month (T1) after the MenC conjugate booster vaccination.
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    83 [56]
    86 [57]
    75 [58]
    Units: ng/mL
        geometric mean (confidence interval 95%)
    35.4 (25.2 to 49.7)
    87.1 (67.7 to 112.2)
    99.2 (70.4 to 139.6)
    Notes
    [56] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [57] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [58] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 10 vs. 12 at T1
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T1 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    169
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [59]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [59] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 10 vs. 15 at T1
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T1 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    158
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [60]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [60] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 12 vs. 15 at T1
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T1 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    161
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [61]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [61] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgA in saliva at T2

    Close Top of page
    End point title
    GMC MenC-PS specific IgA in saliva at T2
    End point description
    Geometric mean concentrations (GMCs) of MenC-polysaccharide specific IgA in saliva 1 Year (T2) after the MenC conjugate booster vaccination.
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    83 [62]
    86 [63]
    75 [64]
    Units: ng/mL
        geometric mean (confidence interval 95%)
    12.4 (9.6 to 15.9)
    25.1 (19.7 to 32.1)
    28.5 (21.9 to 37.0)
    Notes
    [62] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [63] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    [64] - Only participants with sufficient amounts of saliva and serum available to perform all measurements.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 10 vs. 12 at T2
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T2 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    169
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.006 [65]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [65] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 10 vs. 15 at T2
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T2 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    158
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.057 [66]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [66] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgA in saliva 12 vs. 15 at T2
    Statistical analysis description
    Comparisons of GMC MenC-PS specific IgA in saliva at T2 between age groups were made using linear regression analyses with correction for values at T0. All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    161
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [67]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [67] - All p-values for these analyses were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG1 antibodies at T0

    Close Top of page
    End point title
    GMC MenC-PS specific IgG1 antibodies at T0
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1).
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    91
    91
    86
    Units: ug/mL
        geometric mean (confidence interval 95%)
    0.34 (0.29 to 0.41)
    0.34 (0.27 to 0.44)
    0.34 (0.27 to 0.43)
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 12 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    12 year olds v 10 year olds
    Number of subjects included in analysis
    182
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [68]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [68] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [69]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [69] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 12 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [70]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [70] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG1 antibodies at T1

    Close Top of page
    End point title
    GMC MenC-PS specific IgG1 antibodies at T1
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1).
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: ug/mL
        geometric mean (confidence interval 95%)
    158.6 (138.2 to 181.9)
    213.4 (183.4 to 248.3)
    168.7 (139.5 to 203.9)
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 12 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.015 [71]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [71] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [72]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [72] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 12 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.174 [73]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [73] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG1 antibodies at T2

    Close Top of page
    End point title
    GMC MenC-PS specific IgG1 antibodies at T2
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1).
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: ug/mL
        geometric mean (confidence interval 95%)
    13.21 (11.32 to 15.42)
    22.22 (18.51 to 26.68)
    26.29 (22.39 to 30.88)
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 12 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [74]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [74] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [75]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [75] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 12 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.531 [76]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [76] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG2 antibodies at T0

    Close Top of page
    End point title
    GMC MenC-PS specific IgG2 antibodies at T0
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 2 (IgG2).
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    82 [77]
    86 [78]
    86
    Units: ug/mL
        geometric mean (confidence interval 95%)
    0.09 (0.08 to 0.11)
    0.13 (0.11 to 0.17)
    0.16 (0.12 to 0.21)
    Notes
    [77] - Concentration IgG2 too low to measure in nine participants; GMC IgG2 presented from 82 participants
    [78] - Concentration IgG2 too low to measure in five participants; GMC IgG2 presented from 86 participants.
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 12 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.024 [79]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [79] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.003 [80]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [80] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG2 12 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [81]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [81] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG2 antibodies at T1

    Close Top of page
    End point title
    GMC MenC-PS specific IgG2 antibodies at T1
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 2 (IgG2).
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: ug/mL
        geometric mean (confidence interval 95%)
    14.0 (11.1 to 187.7)
    28.0 (23.3 to 33.6)
    30.5 (23.9 to 38.9)
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 12 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.003 [82]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [82] - * P-values were adjusted for three comparisons with Bonferroni
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [83]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [83] - * P-values were adjusted for three comparisons with Bonferroni
    Statistical analysis title
    GMC MenC-PS specific IgG2 12 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [84]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [84] - * P-values were adjusted for three comparisons with Bonferroni

    Secondary: GMC MenC-PS specific IgG2 antibodies at T2

    Close Top of page
    End point title
    GMC MenC-PS specific IgG2 antibodies at T2
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 2 (IgG2).
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: ug/mL
        geometric mean (confidence interval 95%)
    1.28 (1.02 to 1.59)
    3.23 (2.54 to 4.12)
    5.32 (3.99 to 7.10)
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 12 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. * P-values were adjusted for three comparisons with Bonferroni correction. Extensive results of the crude a
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [85]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [85] - * P-values were adjusted for three comparisons with Bonferroni
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. * P-values were adjusted for three comparisons with Bonferroni correction. Extensive results of the crude a
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [86]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [86] - * P-values were adjusted for three comparisons with Bonferroni
    Statistical analysis title
    GMC MenC-PS specific IgG2 12 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. * P-values were adjusted for three comparisons with Bonferroni correction. Extensive results of the crude a
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.531 [87]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [87] - * P-values were adjusted for three comparisons with Bonferroni

    Secondary: Ratio MenC-PS specific IgG1/IgG2 antibodies at T0

    Close Top of page
    End point title
    Ratio MenC-PS specific IgG1/IgG2 antibodies at T0
    End point description
    Ratio of the Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1) and Immunoglobulin G Subclass 2 (IgG2) at T0.
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    82 [88]
    86 [89]
    86
    Units: ratio IgG1 / IgG2
        number (confidence interval 95%)
    3.98 (3.23 to 4.91)
    2.71 (2.23 to 3.30)
    2.17 (1.68 to 2.79)
    Notes
    [88] - Concentration IgG2 too low to measure in nine participants; ratio presented from 82 participants
    [89] - Concentration IgG2 too low to measure in five participants; ratio presented from 86 participants
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ratio 10 vs. 12 at T0
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.027 [90]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [90] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ratio 10 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [91]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [91] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ratio 12 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.522 [92]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [92] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Ratio MenC-PS specific IgG1/IgG2 antibodies at T1

    Close Top of page
    End point title
    Ratio MenC-PS specific IgG1/IgG2 antibodies at T1
    End point description
    Ratio of the Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1) and Immunoglobulin G Subclass 2 (IgG2) at T1.
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: Ratio IgG1/IgG2
        number (confidence interval 95%)
    11.30 (9.44 to 13.51)
    7.59 (6.40 to 9.00)
    5.54 (4.31 to 7.10)
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ration 10 vs. 12 at T1
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.255 [93]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [93] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ration 10 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.054 [94]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [94] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ration 12 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.276 [95]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [95] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Ratio MenC-PS specific IgG1/IgG2 antibodies at T2

    Close Top of page
    End point title
    Ratio MenC-PS specific IgG1/IgG2 antibodies at T2
    End point description
    Ratio of the Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1) and Immunoglobulin G Subclass 2 (IgG2) at T2.
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: Ratio IgG1/IgG2
        number (confidence interval 95%)
    10.36 (8.36 to 12.84)
    6.87 (5.61 to 8.42)
    4.94 (3.73 to 6.55)
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ratio 10 vs. 12 at T2
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.969 [96]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [96] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ratio 10 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.156 [97]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [97] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    MenC-PS IgG1/IgG2 subclass ratio 12 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.297 [98]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [98] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Mean MenC-PS IgG avidity index age 10

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index age 10
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group prior to (T0) and 1 month (T1) and 1 year (T2) after the MenC conjugate booster. Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses (44 10-year-olds, 49 12-year-olds and 60 15-year-olds). Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T0, T1, T2 and T3 of age group 10 years old.
    End point values
    Age group 10 at T0 Age group 10 at T1 Age group 10 at T2 Age group 10 at T3
    Number of subjects analysed
    44 [99]
    43 [100]
    42 [101]
    22 [102]
    Units: Avidity Index
        arithmetic mean (confidence interval 95%)
    45.77 (41.20 to 50.33)
    43.04 (38.32 to 47.75)
    44.54 (40.94 to 48.13)
    43.33 (35.93 to 50.73)
    Notes
    [99] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [100] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [101] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [102] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index age 10 T0 vs. T1
    Statistical analysis description
    Paired sample t-test avidity index age group 10 year old for T0 and T1.
    Comparison groups
    Age group 10 at T0 v Age group 10 at T1
    Number of subjects included in analysis
    87
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.3127
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 10 T0 vs. T2
    Statistical analysis description
    Paired sample t-test avidity index age group 10 year old for T0 and T2.
    Comparison groups
    Age group 10 at T0 v Age group 10 at T2
    Number of subjects included in analysis
    86
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.3975
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 10 T1 vs. T2
    Statistical analysis description
    Paired sample t-test avidity index age group 10 year old for T1 and T2.
    Comparison groups
    Age group 10 at T2 v Age group 10 at T1
    Number of subjects included in analysis
    85
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.6349
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 10 T2 vs. T3
    Statistical analysis description
    Paired sample t-test avidity index age group 10 year old for T2 and T3.
    Comparison groups
    Age group 10 at T2 v Age group 10 at T3
    Number of subjects included in analysis
    64
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.9924
    Method
    paired sample t-test
    Confidence interval

    Secondary: Mean MenC-PS IgG avidity index age 12

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index age 12
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group prior to (T0) and 1 month (T1) and 1 year (T2) after the MenC conjugate booster. Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses (44 10-year-olds, 49 12-year-olds and 60 15-year-olds). Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T0, T1, T2 and T3 of age group 12 years old.
    End point values
    Age group 12 at T0 Age group 12 at T1 Age group 12 at T2 Age group 12 at T3
    Number of subjects analysed
    49 [103]
    48 [104]
    48 [105]
    32 [106]
    Units: Avidity Index
        arithmetic mean (confidence interval 95%)
    47.22 (43.16 to 51.27)
    47.28 (43.29 to 51.26)
    48.43 (45.15 to 51.72)
    48.65 (42.33 to 54.96)
    Notes
    [103] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [104] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [105] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [106] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index age 12 T0 vs. T1
    Statistical analysis description
    Paired sample t-test avidity index age group 12 year old for T0 and T1.
    Comparison groups
    Age group 12 at T0 v Age group 12 at T1
    Number of subjects included in analysis
    97
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.9792
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 12 T0 vs. T2
    Statistical analysis description
    Paired sample t-test avidity index age group 12 year old for T0 and T2.
    Comparison groups
    Age group 12 at T0 v Age group 12 at T2
    Number of subjects included in analysis
    97
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.6209 [107]
    Method
    paired sample t-test
    Confidence interval
    Notes
    [107] - not significant
    Statistical analysis title
    Avidity index age 12 T1 vs. T2
    Statistical analysis description
    Paired sample t-test avidity index age group 12 year old for T1 and T2.
    Comparison groups
    Age group 12 at T2 v Age group 12 at T1
    Number of subjects included in analysis
    96
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5851
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 12 T2 vs. T3
    Statistical analysis description
    Paired sample t-test avidity index age group 12 year old for T2 and T3.
    Comparison groups
    Age group 12 at T2 v Age group 12 at T3
    Number of subjects included in analysis
    80
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5762
    Method
    paired sample t-test
    Confidence interval

    Secondary: Mean MenC-PS IgG avidity index age 15

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index age 15
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group prior to (T0) and 1 month (T1) and 1 year (T2) after the MenC conjugate booster. Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses (44 10-year-olds, 49 12-year-olds and 60 15-year-olds). Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T0, T1, T2 and T3 of age group 15 years old.
    End point values
    Age group 15 at T0 Age group 15 at T1 Age group 15 at T2 Age group 15 at T3
    Number of subjects analysed
    60 [108]
    60 [109]
    59 [110]
    25 [111]
    Units: Avidity index
        arithmetic mean (confidence interval 95%)
    41.67 (37.06 to 46.28)
    50.76 (46.83 to 54.96)
    46.79 (43.53 to 50.05)
    46.08 (39.39 to 52.78)
    Notes
    [108] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [109] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [110] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [111] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index age 15 T0 vs. T1
    Statistical analysis description
    Paired sample t-test avidity index age group 15 year old for T0 and T1.
    Comparison groups
    Age group 15 at T0 v Age group 15 at T1
    Number of subjects included in analysis
    120
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0027
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 15 T0 vs. T2
    Statistical analysis description
    Paired sample t-test avidity index age group 15 year old for T0 and T2.
    Comparison groups
    Age group 15 at T0 v Age group 15 at T2
    Number of subjects included in analysis
    119
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.044
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 15 T1 vs. T2
    Statistical analysis description
    Paired sample t-test avidity index age group 15 year old for T1 and T2.
    Comparison groups
    Age group 15 at T2 v Age group 15 at T1
    Number of subjects included in analysis
    119
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0006
    Method
    paired sample t-test
    Confidence interval
    Statistical analysis title
    Avidity index age 15 T2 vs. T3
    Statistical analysis description
    Paired sample t-test avidity index age group 15 year old for T2 and T3.
    Comparison groups
    Age group 15 at T2 v Age group 15 at T3
    Number of subjects included in analysis
    84
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0029
    Method
    paired sample t-test
    Confidence interval

    Secondary: GMC of Tetanus Toxoid specific IgG at T0

    Close Top of page
    End point title
    GMC of Tetanus Toxoid specific IgG at T0
    End point description
    Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) prior to (T0) the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    91
    91
    86
    Units: ug/mL
        geometric mean (confidence interval 95%)
    5.1 (4.3 to 6.0)
    1.6 (1.3 to 1.9)
    0.7 (0.6 to 0.8)
    Statistical analysis title
    GMT TT IgG levels 10 vs. 12 at T0
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    182
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [112]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [112] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT TT IgG levels 10 vs. 15 at T0
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [113]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [113] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMT TT IgG levels 12 vs.15 at T0
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    177
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [114]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [114] - * P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC of Tetanus Toxoid specific IgG at T1

    Close Top of page
    End point title
    GMC of Tetanus Toxoid specific IgG at T1
    End point description
    Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) 1 Month (T1) after the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: ug/mL
        geometric mean (confidence interval 95%)
    7.4 (6.5 to 8.5)
    4.4 (3.4 to 5.1)
    2.9 (2.4 to 3.5)
    Statistical analysis title
    GMC TT IgG levels 10 vs. 12 at T1
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.069 [115]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [115] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC TT IgG levels 10 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.213 [116]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [116] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC TT IgG levels 12 vs. 15 at T1
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 1 [117]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [117] - * P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC of Tetanus Toxoid specific IgG at T2

    Close Top of page
    End point title
    GMC of Tetanus Toxoid specific IgG at T2
    End point description
    Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) 1 Year (T2) after the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: ug/mL
        geometric mean (confidence interval 95%)
    3.6 (3.1 to 4.2)
    1.9 (1.6 to 2.2)
    1.1 (1.0 to 1.4)
    Statistical analysis title
    GMC TT IgG levels 10 vs. 12 at T2
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.006 [118]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [118] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC TT IgG levels 10 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.153 [119]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [119] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC TT IgG levels 12 vs. 15 at T2
    Statistical analysis description
    Differences between age groups in GMC of TT-specific IgG were determined with linear regression analyses, adjusting for concentrations at T0. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.186 [120]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [120] - * P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Ratio of GMC TT IgG levels T1/T0

    Close Top of page
    End point title
    Ratio of GMC TT IgG levels T1/T0
    End point description
    Ratio of the Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific IgG prior to (T0) and 1 month (T1) after the Menongococcal Serogroup C tetanus Toxoid Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T1 versus T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88
    90
    85
    Units: GCM ratio T1/T0
        number (confidence interval 95%)
    1.49 (1.34 to 1.64)
    2.75 (2.42 to 3.13)
    4.26 (3.59 to 5.05)
    Statistical analysis title
    Ratio of GMC TT IgG levels T1/T0 10 vs. 12 years
    Statistical analysis description
    GMC ratios indicate the level of increase (T1/T0) of Tetanus Toxiod specific IgG between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    178
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [121]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [121] - * P-values were adjusted for three comparisons with Bonfe
    Statistical analysis title
    Ratio of GMC TT IgG levels T1/T0 10 vs. 15 years
    Statistical analysis description
    GMC ratios indicate the level of increase (T1/T0) of Tetanus Toxiod specific IgG between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    173
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [122]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [122] - * P-values were adjusted for three comparisons with Bonfe
    Statistical analysis title
    Ratio of GMC TT IgG levels T1/T0 12 vs. 15 years
    Statistical analysis description
    GMC ratios indicate the level of increase (T1/T0) of Tetanus Toxiod specific IgG between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    175
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [123]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [123] - * P-values were adjusted for three comparisons with Bonfe

    Secondary: Ratio of GMC TT IgG levels T1/T2

    Close Top of page
    End point title
    Ratio of GMC TT IgG levels T1/T2
    End point description
    Ratio of the Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific IgG 1 month (T1) and 1 year (T2) after the Menongococcal Serogroup C tetanus Toxoid Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T1 versus T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    85
    89
    83
    Units: GMC ratio T1/T2
        number (confidence interval 95%)
    2.03 (1.89 to 2.18)
    2.34 (2.14 to 2.55)
    2.50 (2.27 to 2.75)
    Statistical analysis title
    Ratio of GMC TT IgG levels T1/T2 10 vs. 12 years
    Statistical analysis description
    GMC ratios indicate the level of decrease (T1/T2) of Tetanus Toxoid (TT) specific IgG between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    174
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.048 [124]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [124] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    Ratio of GMC TT IgG levels T1/T2 10 vs. 15 years
    Statistical analysis description
    GMC ratios indicate the level of decrease (T1/T2) of Tetanus Toxoid (TT) specific IgG between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    168
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.001 [125]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [125] - * P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    Ratio of GMC TT IgG levels T1/T2 12 vs. 15 years
    Statistical analysis description
    GMC ratios indicate the level of decrease (T1/T2) of Tetanus Toxoid (TT) specific IgG between time points. Differences in GMC ratios between groups were determined with independent sample t-tests. * P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    172
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.921 [126]
    Method
    t-test, 2-sided
    Confidence interval
    Notes
    [126] - * P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Mean MenC-PS IgG avidity index T0

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index T0
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group prior to (T0) the MenC conjugate booster. Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses (44 10-year-olds, 49 12-year-olds and 60 15-year-olds). Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    44 [127]
    49 [128]
    60 [129]
    Units: Avidity Index
        arithmetic mean (confidence interval 95%)
    45.77 (41.20 to 50.33)
    47.22 (43.16 to 51.27)
    41.67 (37.06 to 46.28)
    Notes
    [127] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [128] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [129] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index T0 10 vs. 12 years old
    Statistical analysis description
    T-test on the mean avidity index at T0 for age groups 10 and 12 years old.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    93
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.6342
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T0 10 vs. 15 years old
    Statistical analysis description
    T-test on the mean avidity index at T0 for age groups 10 and 15 years old.
    Comparison groups
    15 year olds v 10 year olds
    Number of subjects included in analysis
    104
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.2076
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T0 12 vs. 15 years old
    Statistical analysis description
    T-test on the mean avidity index at T0 for age groups 12 and 15 years old.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    109
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1564
    Method
    t-test, 2-sided
    Confidence interval

    Secondary: Mean MenC-PS IgG avidity index T1

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index T1
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group 1 month after the MenC conjugate booster (T1). Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses. Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    43 [130]
    48 [131]
    60 [132]
    Units: Avidity Index
        arithmetic mean (confidence interval 95%)
    43.04 (38.32 to 47.75)
    47.28 (43.29 to 51.26)
    50.76 (46.83 to 54.96)
    Notes
    [130] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [131] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [132] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index T1 10 vs. 12 years old
    Statistical analysis description
    T-test of mean avidity index at T1 for groups 10 and 12 years old.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    91
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1701
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T1 10 vs. 15 years old
    Statistical analysis description
    T-test of mean avidity index at T1 for groups 10 and 15 years old.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    103
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0131
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T1 12 vs. 15 years old
    Statistical analysis description
    T-test of mean avidity index at T1 for groups 12 and 15 years old.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    108
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.2148
    Method
    t-test, 2-sided
    Confidence interval

    Secondary: Mean MenC-PS IgG avidity index T2

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index T2
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group 1 year after the MenC conjugate booster (T2). Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses. Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    42 [133]
    48 [134]
    59 [135]
    Units: Avidity Index
        arithmetic mean (confidence interval 95%)
    44.54 (40.94 to 48.13)
    48.43 (45.15 to 51.72)
    46.79 (43.53 to 50.05)
    Notes
    [133] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [134] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [135] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index T2 10 vs. 12 years old
    Statistical analysis description
    T-test of mean avidity index at T2 for groups 10 and 12 years old.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    90
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1105
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T2 10 vs. 15 years old
    Statistical analysis description
    T-test of mean avidity index at T2 for groups 10 and 15 years old.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    101
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.3533
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T2 12 vs. 15 years old
    Statistical analysis description
    T-test of mean avidity index at T2 for groups 12 and 15 years old.
    Comparison groups
    12 year olds v 15 year olds
    Number of subjects included in analysis
    107
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.4775
    Method
    t-test, 2-sided
    Confidence interval

    Secondary: Mean MenC-PS IgG avidity index T3

    Close Top of page
    End point title
    Mean MenC-PS IgG avidity index T3
    End point description
    Meningococcal Serogroup C Polysaccharide Specific Immunoglobulin G (IgG) Avidity Indices (AI). Mean avidity indices per age group 3 years after the MenC conjugate booster (T3). Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included in the analyses. Serum samples were diluted to a concentration of 25 ng/ml. Avidity index = (amount of IgG still bound after treatment with 0.5 M NH4SCN/amount of IgG with PBS) x 100.
    End point type
    Secondary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    22 [136]
    32 [137]
    25 [138]
    Units: Avidity Index
        arithmetic mean (confidence interval 95%)
    43.33 (35.93 to 50.73)
    48.65 (42.33 to 54.96)
    46.08 (39.39 to 52.78)
    Notes
    [136] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [137] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    [138] - Only serum samples from participants with an IgG concentration of >=0.25 mg/ml at T0 were included.
    Statistical analysis title
    Avidity index T3 10 vs. 12 years old
    Statistical analysis description
    T-test of mean avidity index at T3 for age groups 10 and 12 years old.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    54
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.2658
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T3 10 vs. 15 years old
    Statistical analysis description
    T-test of mean avidity index at T3 for age groups 10 and 15 years old.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    47
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5705
    Method
    t-test, 2-sided
    Confidence interval
    Statistical analysis title
    Avidity index T3 12 vs. 15 years old
    Statistical analysis description
    T-test of mean avidity index at T3 for age groups 12 and 15 years old.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    57
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5701
    Method
    t-test, 2-sided
    Confidence interval

    Secondary: GMC MenC-PS specific IgG antibodies at T3

    Close Top of page
    End point title
    GMC MenC-PS specific IgG antibodies at T3
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G (IgG) 3 years (T3) after the MenC Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: ug/mL
        geometric mean (confidence interval 95%)
    6.4 (5.3 to 7.7)
    14 (11 to 17)
    19 (16 to 23)
    Statistical analysis title
    GMC MenC-PS specific IgG 10 vs. 12 at T3
    Statistical analysis description
    Differences between age groups in GMC MenC-PS IgG at T3 were determined with linear regression analyses, adjusting for titers and concentrations before the booster vaccination. All P-values were adjusted for three comparisons with the Bonferroni correction.
    Comparison groups
    12 year olds v 10 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [139]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [139] - All P-values were adjusted for three comparisons with the Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG 10 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in GMC MenC-PS IgG at T3 were determined with linear regression analyses, adjusting for titers and concentrations before the booster vaccination. All P-values were adjusted for three comparisons with the Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [140]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [140] - All P-values were adjusted for three comparisons with the Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG 12 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in GMC MenC-PS IgG at T3 were determined with linear regression analyses, adjusting for titers and concentrations before the booster vaccination. All P-values were adjusted for three comparisons with the Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.267 [141]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [141] - All P-values were adjusted for three comparisons with the Bonferroni correction.

    Secondary: GMC of Tetanus Toxoid specific IgG at T3

    Close Top of page
    End point title
    GMC of Tetanus Toxoid specific IgG at T3
    End point description
    Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) 3 years (T3) after the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster.
    End point type
    Secondary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: ug/mL
        geometric mean (confidence interval 95%)
    1.37 (1.2 to 1.6)
    0.87 (0.7 to 1.1)
    0.60 (0.5 to 0.8)
    Statistical analysis title
    GMC Tetanus Toxoid specific IgG 10 vs. 12 at T3
    Statistical analysis description
    Differences in Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) 3 years (T3) after the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster were determined with linear regression, adjusting for concentrations before the booster vaccination. All P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [142]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [142] - All P-values were adjusted for three comparisons with the Bonferroni correction.
    Statistical analysis title
    GMC Tetanus Toxoid specific IgG 10 vs. 15 at T3
    Statistical analysis description
    Differences in Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) 3 years (T3) after the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster were determined with linear regression, adjusting for concentrations before the booster vaccination. All P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.001 [143]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [143] - All P-values were adjusted for three comparisons with the Bonferroni correction.
    Statistical analysis title
    GMC Tetanus Toxoid specific IgG 12 vs. 15 at T3
    Statistical analysis description
    Differences in Geometric Mean Concentrations (GMCs) of Tetanus Toxoid (TT) Specific Immunoglobulin G (IgG) 3 years (T3) after the Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster were determined with linear regression, adjusting for concentrations before the booster vaccination. All P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [144]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [144] - All P-values were adjusted for three comparisons with the Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG1 antibodies at T3

    Close Top of page
    End point title
    GMC MenC-PS specific IgG1 antibodies at T3
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1) 3 years (T3) after booster vaccination.
    End point type
    Secondary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: ug/mL
        geometric mean (confidence interval 95%)
    9.42 (7.97 to 11.15)
    18.20 (14.96 to 22.14)
    21.47 (18.28 to 25.21)
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 12 at T3
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [145]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [145] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 10 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [146]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [146] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG1 12 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 1 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.354 [147]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [147] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: GMC MenC-PS specific IgG2 antibodies at T3

    Close Top of page
    End point title
    GMC MenC-PS specific IgG2 antibodies at T3
    End point description
    Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 2 (IgG2) 3 years (T3) after booster vaccination.
    End point type
    Secondary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: ug/mL
        geometric mean (confidence interval 95%)
    0.79 (0.60 to 1.03)
    2.06 (1.60 to 2.65)
    3.66 (2.55 to 5.26)
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 12 at T3
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [148]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [148] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG2 10 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    < 0.001 [149]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [149] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    GMC MenC-PS specific IgG2 12 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in GMC of MenC-PS specific IgG subclass 2 were determined with linear regression analyses, adjusting for concentrations and ratios at T0. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.297 [150]
    Method
    Regression, Linear
    Confidence interval
    Notes
    [150] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Ratio MenC-PS specific IgG1/IgG2 antibodies at T3

    Close Top of page
    End point title
    Ratio MenC-PS specific IgG1/IgG2 antibodies at T3
    End point description
    Ratio of the Geometric Mean Concentrations (GMCs) of Meningococcal Serogroup C Polysaccharide (MenC-PS) Specific Immunoglobulin G Subclass 1 (IgG1) and Immunoglobulin G Subclass 2 (IgG2) at T3.
    End point type
    Secondary
    End point timeframe
    T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    66
    75
    58
    Units: Ratio IgG1/IgG2
        number (confidence interval 95%)
    11.4 (8.9 to 14.6)
    8.8 (7.1 to 11.0)
    5.9 (4.1 to 8.3)
    Statistical analysis title
    Ratio MenC-PS IgG1/IgG levels 10 vs. 12 at T3
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with independent sample t-test. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    141
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.447 [151]
    Method
    independent sample t-test
    Confidence interval
    Notes
    [151] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    Ratio MenC-PS IgG1/IgG levels 10 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with independent sample t-test. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    124
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.003 [152]
    Method
    independent sample t-test
    Confidence interval
    Notes
    [152] - P-values were adjusted for three comparisons with Bonferroni correction.
    Statistical analysis title
    Ratio MenC-PS IgG1/IgG levels 12 vs. 15 at T3
    Statistical analysis description
    Differences between age groups in MenC-PS specific IgG1 / IgG2 subclass ratio were determined with independent sample t-test. P-values were adjusted for three comparisons with Bonferroni correction.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    133
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.06 [153]
    Method
    independent sample t-test
    Confidence interval
    Notes
    [153] - P-values were adjusted for three comparisons with Bonferroni correction.

    Secondary: Decay of SBA titer below 8 (50% predicted interval)

    Close Top of page
    End point title
    Decay of SBA titer below 8 (50% predicted interval)
    End point description
    Predicted time after the meningococcal serogroup C conjugated to tetanus toxoid (MenC-TT) booster vaccination to fall below an rSBA titer of 8 for the three age groups estimated by the bi-exponential decay model. Calculated median duration of protection (50% predicted interval).
    End point type
    Secondary
    End point timeframe
    T0 - T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88 [154]
    89 [155]
    85 [156]
    Units: years
        number (not applicable)
    16.3
    45.9
    270
    Notes
    [154] - Samples from T0 to T3 were used.
    [155] - Samples from T0 to T3 were used.
    [156] - Samples from T0 to T3 were used.
    No statistical analyses for this end point

    Secondary: Decay of SBA titer below 8 (5% predicted interval)

    Close Top of page
    End point title
    Decay of SBA titer below 8 (5% predicted interval)
    End point description
    Predicted time after the meningococcal serogroup C conjugated to tetanus toxoid (MenC-TT) booster vaccination to fall below an rSBA titer of 8 for the three age groups estimated by the bi-exponential decay model. The estimated minimal duration of protection after this booster vaccination (5% predicted interval).
    End point type
    Secondary
    End point timeframe
    T0-T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88 [157]
    89 [158]
    85 [159]
    Units: years
        number (not applicable)
    8.7
    16.3
    29.0
    Notes
    [157] - Samples from T0 to T3 were used.
    [158] - Samples from T0 to T3 were used.
    [159] - Samples from T0 to T3 were used.
    No statistical analyses for this end point

    Secondary: Decay of SBA titer below 128 (50% predicted interval)

    Close Top of page
    End point title
    Decay of SBA titer below 128 (50% predicted interval)
    End point description
    Predicted time after the meningococcal serogroup C conjugated to tetanus toxoid (MenC-TT) booster vaccination to fall below an rSBA titer of 128 for the three age groups estimated by the bi-exponential decay model. Calculated median duration of protection (50% predicted interval).
    End point type
    Secondary
    End point timeframe
    T0-T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88 [160]
    89 [161]
    85 [162]
    Units: years
        number (not applicable)
    7.7
    24.4
    145
    Notes
    [160] - Samples from T0 to T3 were used.
    [161] - Samples from T0 to T3 were used.
    [162] - Samples from T0 to T3 were used.
    No statistical analyses for this end point

    Secondary: Decay of SBA titer below 128 (5% predicted interval)

    Close Top of page
    End point title
    Decay of SBA titer below 128 (5% predicted interval)
    End point description
    Predicted time after the meningococcal serogroup C conjugated to tetanus toxoid (MenC-TT) booster vaccination to fall below an rSBA titer of 128 for the three age groups estimated by the bi-exponential decay model. The estimated minimal duration of protection after this booster vaccination (5% predicted interval).
    End point type
    Secondary
    End point timeframe
    T0-T3
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    88 [163]
    89 [164]
    85 [165]
    Units: years
        number (not applicable)
    3.4
    8.2
    16.3
    Notes
    [163] - Samples from T0 to T3 were used.
    [164] - Samples from T0 to T3 were used.
    [165] - Samples from T0 to T3 were used.
    No statistical analyses for this end point

    Secondary: Men-C PS specific IgA memory B-cell responses at T0

    Close Top of page
    End point title
    Men-C PS specific IgA memory B-cell responses at T0
    End point description
    Frequency of circulating MenC-PS-specific IgA memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    6
    10
    9
    Units: Men-C IgA memory B cells
        geometric mean (confidence interval 95%)
    0.06 (0.003 to 1.07)
    0.09 (0.01 to 0.65)
    0.06 (0.007 to 0.48)
    Statistical analysis title
    Men-C PS IgA memory B cells 10 vs. 12 at T0
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    16
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.7602
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgA memory B cells 10 vs. 15 at T0
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    15
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    > 0.9999
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgA memory B cells 12 vs. 15 at T0
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    19
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.7942
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Men-C PS specific IgA memory B-cell responses at T1

    Close Top of page
    End point title
    Men-C PS specific IgA memory B-cell responses at T1
    End point description
    Frequency of circulating MenC-PS-specific IgA memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    7
    11
    8
    Units: MenC IgA memory B cells
        geometric mean (confidence interval 95%)
    3.27 (0.22 to 49.23)
    43.55 (27.83 to 68.15)
    32.41 (12.68 to 82.87)
    Statistical analysis title
    Men-C PS IgA memory B cells 10 vs. 12 at T1
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    18
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0165
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgA memory B cells 10 vs. 15 at T1
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    15
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0401
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgA memory B cells 12 vs. 15 at T1
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    19
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5304
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Men-C PS specific IgA memory B-cell responses at T2

    Close Top of page
    End point title
    Men-C PS specific IgA memory B-cell responses at T2
    End point description
    Frequency of circulating MenC-PS-specific IgA memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    5
    11
    11
    Units: MenC IgA memory B cells
        geometric mean (confidence interval 95%)
    0.29 (0.006 to 13.41)
    2.00 (0.33 to 12.19)
    2.81 (0.65 to 12.18)
    Statistical analysis title
    Men-C PS IgA memory B cells 10 vs. 12 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    16
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0847
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgA memory B cells 10 vs. 15 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    16
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1346
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Men-C PS IgA memory B cells 12 vs. 15 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating MenC-PS-specific IgA memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of MenC-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    22
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.96
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Tetanus Toxoid specific IgG memory B-cell responses at T0

    Close Top of page
    End point title
    Tetanus Toxoid specific IgG memory B-cell responses at T0
    End point description
    Frequency of circulating Tetanus Toxoid specific IgG memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of TT memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T0
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    17
    13
    14
    Units: TT IgG memory B cells
        geometric mean (confidence interval 95%)
    10.29 (3.81 to 27.81)
    5.53 (1.53 to 20.01)
    1.29 (0.26 to 6.42)
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 10 vs. 12 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    30
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1938
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 10 vs. 15 at T0
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    31
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0007
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 12 vs. 15 at T0
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells prior to (T0) the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    27
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.0865
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Tetanus Toxoid specific IgG memory B-cell responses at T1

    Close Top of page
    End point title
    Tetanus Toxoid specific IgG memory B-cell responses at T1
    End point description
    Frequency of circulating Tetanus Toxoid specific IgG memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of TT memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T1
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    18
    14
    17
    Units: Tetanus toxoid IgG memory B cells
        geometric mean (confidence interval 95%)
    17.09 (11.47 to 25.48)
    21.78 (12.62 to 37.59)
    7.53 (1.99 to 28.52)
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 10 vs. 12 at T1
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    32
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.3141
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 10 vs 15 at T1
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    35
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.6656
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 12 vs. 15 at T1
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells 1 month (T1) after the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    31
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.1701
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Secondary: Tetanus Toxoid specific IgG memory B-cell responses at T2

    Close Top of page
    End point title
    Tetanus Toxoid specific IgG memory B-cell responses at T2
    End point description
    Frequency of circulating Tetanus Toxoid specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of TT memory B cells per 100,000 B cells
    End point type
    Secondary
    End point timeframe
    T2
    End point values
    10 year olds 12 year olds 15 year olds
    Number of subjects analysed
    17
    13
    16
    Units: Tetanus Toxoid IgG memory B cells
        geometric mean (confidence interval 95%)
    3.80 (1.07 to 13.50)
    6.44 (1.91 to 21.75)
    2.68 (0.68 to 10.50)
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 10 vs. 12 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 12 year olds
    Number of subjects included in analysis
    30
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5701
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 10 vs. 15 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    10 year olds v 15 year olds
    Number of subjects included in analysis
    33
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.5507
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval
    Statistical analysis title
    Tetanus Toxoid IgG memory B cells 12 vs. 15 at T2
    Statistical analysis description
    Mann-Whitney U test on circulating Tetanus Toxoid specific IgG memory B cells 1 year (T2) after the MenC conjugate booster vaccination. Geometric mean number of TT-specific memory B cells per 100,000 B cells.
    Comparison groups
    15 year olds v 12 year olds
    Number of subjects included in analysis
    29
    Analysis specification
    Pre-specified
    Analysis type
    equivalence
    P-value
    = 0.3566
    Method
    Wilcoxon (Mann-Whitney)
    Confidence interval

    Adverse events

    Close Top of page
    Adverse events information
    Timeframe for reporting adverse events
    Adverse events (AEs) are defined as any undesirable experience occurring to a participant during the study, whether or not considered related to the vaccine, the vaccination or the venapuncture.
    Adverse event reporting additional description
    There were no SAEs and SUSARs.
    Assessment type
    Non-systematic
    Dictionary used for adverse event reporting
    Dictionary name
    MedDRA
    Dictionary version
    27
    Reporting groups
    Reporting group title
    Self reported Adverse event
    Reporting group description
    All adverse events reported spontaneously by the participant, his/her parent(s) or observed by the principal investiga¬tor or her staff .

    Serious adverse events
    Self reported Adverse event
    Total subjects affected by serious adverse events
         subjects affected / exposed
    0 / 268 (0.00%)
         number of deaths (all causes)
    0
         number of deaths resulting from adverse events
    0
    Frequency threshold for reporting non-serious adverse events: 0.05%
    Non-serious adverse events
    Self reported Adverse event
    Total subjects affected by non serious adverse events
         subjects affected / exposed
    1 / 268 (0.37%)
    Injury, poisoning and procedural complications
    Immunisation reaction
    Additional description: one subject had multiple reactions; headache, dizziness, and a feeling of swelling and pain in the throat. And atypical vasovagal reaction after venipuncture and vaccination/ mild allergic reaction after vaccination.
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1
    Nervous system disorders
    Headache
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1
    Dizziness
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1
    Presyncope
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1
    Immune system disorders
    Allergic reaction to excipient
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1
    Respiratory, thoracic and mediastinal disorders
    Pharyngeal swelling
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1
    Oropharyngeal pain
         subjects affected / exposed
    1 / 268 (0.37%)
         occurrences all number
    1

    More information

    Close Top of page

    Substantial protocol amendments (globally)

    Were there any global substantial amendments to the protocol? Yes
    Date
    Amendment
    05 Jun 2014
    For adequate protection against Meningococcal C (MenC), sufficient circulating antibodies are required. The first results of the TIM study show that all 10-, 12- and 15-year-olds in the study still have more than enough antibodies 1 year after the study vaccination (booster). However, the rate of decline of the circulating antibodies seems to be the least rapid in the 15-year-olds. We want to further monitor the (differences between the age groups in) the rate of decline of MenC-specific antibodies after the study vaccination and therefore are going to take blood and saliva 3 years after the study vaccination.

    Interruptions (globally)

    Were there any global interruptions to the trial? No

    Limitations and caveats

    Limitations of the trial such as small numbers of subjects analysed or technical problems leading to unreliable data.
    Missing data: * Memory T cells were not measured (all time points) * Memory B cell analysis is missing for T3 * IgA in serum and saliva are missing for T3

    Online references

    http://www.ncbi.nlm.nih.gov/pubmed/24963638
    http://www.ncbi.nlm.nih.gov/pubmed/26100925
    http://www.ncbi.nlm.nih.gov/pubmed/26458006
    http://www.ncbi.nlm.nih.gov/pubmed/27817957
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Nov 22 21:12:56 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA